| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | France | 4 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Australia | 1 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Geffard Michel | 13 |
| #2 | Michel Geffard | 1 |
| Publication | Filing date | Title |
|---|---|---|
| FR3048616A1 | POLYCOMPLEXES OF POLY-LYSINE COMPOUNDS FOR THE PREVENTION AND / OR CONTROL OF AMYOTROPHIC LATERAL SCLEROSIS | |
| FR2913335A1 | Use of fatty acid conjugates and poly-l-lysine to combat pathogenic microorganisms. | |
| FR2727117A1 | Use of polylysin conjugates for the preparation of medicaments useful in the treatment of neurodegenerative diseases and degenerative disorders of autoimmun character | |
| FR2705234A1 | Use of molecules recognized by autoantibodies in human sera for the diagnosis or treatment of AIDS. |